Swedish Pharma Stock News

Skanska (OM:SKA B) is back in focus after its AGM approved a total dividend of SEK 14.00 per share, split between an ordinary payout and an extraordinary component that directly affects shareholder cash returns. See our latest analysis for Skanska. The AGM news comes as Skanska’s share price trades at SEK252.6, with a 1 day share price return of 2.27% and a 7 day share price return of 3.02%. The 1 year total shareholder return of 24.75% and 3 year total shareholder return of 81.21% point to...

If you are asking whether EQT is attractively priced right now, the key is to look at what the current share price actually implies about the business. The stock recently closed at SEK 286.5, with returns of 4.6% over 7 days, 2.3% over 30 days, a 20.0% decline year to date, a 7.6% decline over 1 year, and a 42.1% gain over 3 years alongside a 4.9% gain over 5 years. Taken together, this gives a mixed picture of sentiment and risk. Recent coverage around EQT has focused on its role in the...

As European markets navigate the complexities of geopolitical tensions and fluctuating energy prices, the pan-European STOXX Europe 600 Index has shown modest growth, reflecting cautious investor sentiment amidst uncertainties. In this environment, small-cap stocks with strong fundamentals and insider buying can offer intriguing opportunities for investors seeking value in a volatile market.

As the European markets navigate through uncertainty driven by geopolitical tensions and fluctuating energy prices, the pan-European STOXX Europe 600 Index has shown modest gains, reflecting cautious optimism among investors. In this environment, growth companies with high insider ownership can be particularly appealing as they often demonstrate strong alignment between management and shareholder interests, potentially offering resilience amid market volatility.

Amidst the backdrop of geopolitical tensions and fluctuating energy prices, European markets have shown resilience with the STOXX Europe 600 Index posting a modest gain. As investors navigate these uncertain times, identifying stocks that exhibit strong fundamentals and adaptability to economic shifts can be crucial for uncovering potential opportunities.

Amidst ongoing geopolitical tensions and fluctuating energy prices, the European stock market has shown resilience, with the pan-European STOXX Europe 600 Index seeing modest gains. In this uncertain environment, dividend stocks can offer a potential source of income stability; they are often favored for their ability to provide consistent returns even when market conditions are volatile.

NCC (OM:NCC B) has announced several new client contracts, including Arena Fredrikstad in Norway, road works in Norrbotten, a waterworks in Järfälla and a residential care facility in Svalöv, expanding its order book denominated in SEK. See our latest analysis for NCC. These new contracts come as NCC's share price has recently moved to SEK206.8, with a 1-day share price return of 2.68% contrasting with a 30 day share price return decline of 6.17%. Longer term total shareholder returns over...

Viewing insider transactions for Storytel AB (publ)'s ( STO:STORY B ) over the last year, we see that insiders were net...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Barclays highlights Sandvik (OM:SAND) as a key beneficiary of a new mining capex cycle linked to higher gold prices. The bank points to a sector wide pickup in spending on gold projects, with Sandvik positioned for stronger equipment and services demand. The analyst view flags potential double digit growth in orders and revenue tied to this gold focused investment wave. Sandvik, a major supplier of mining equipment and rock processing solutions, sits close to the heart of global capex...

Getinge (OM:GETI B) has drawn fresh attention after recent share performance, with the stock showing mixed returns over the past month and the past three months while value focused investors reassess its current pricing. See our latest analysis for Getinge. At a share price of SEK188.55, Getinge’s recent 7 day share price return of 2.6% contrasts with its 30 day share price return of a 7.1% decline and its 1 year total shareholder return of a 13.1% loss. This suggests momentum has been fading...

Cloetta (OM:CLA B) has come into focus after the board proposed a dividend of SEK 1.40 per share, up from SEK 1.10, alongside growing attention on insider buying and perceived undervaluation. See our latest analysis for Cloetta. At a share price of SEK53.05, Cloetta has delivered a 31.12% 90 day share price return and an 89.19% 1 year total shareholder return, suggesting momentum has been building around the higher proposed dividend and insider interest. If this kind of upswing has you...

Hoist Finance (OM:HOFI) has just introduced HoistSpar in Spain, offering online euro fixed rate savings accounts with 3 to 24 month terms. All deposits are covered by the Swedish deposit guarantee scheme. See our latest analysis for Hoist Finance. The HoistSpar launch in Spain comes after a strong run in Hoist Finance's shares, with a 31.21% 90 day share price return and a very large 3 year total shareholder return. This suggests that momentum has been building rather than fading. If this...

Ericsson has been selected by VTel Wireless to supply a fully native 5G Standalone Core and Radio Access Network in rural United States. The project will enable 5G SA Voice over New Radio roaming without relying on legacy 4G systems. The deployment is expected to support digital inclusion, spectrum consolidation and a scalable model for ultra rural telecom services. For investors watching Telefonaktiebolaget LM Ericsson (OM:ERIC B), this new US rural 5G deal comes with the shares trading...

EMA validates Sobi’s application to extend Tryngolza (olezarsen) to adults with severe hypertriglyceridemia, supported by pivotal Phase 3 data. Tryngolza’s extended indication targets patients at risk of acute pancreatitis where existing treatments often fall short. New Phase 2a data for Gamifant (emapalumab) in IFN-gamma-driven sepsis are presented at ISICEM, covering inflammation-related organ dysfunction and mortality outcomes. Both updates highlight late stage pipeline progress for...

Amidst a backdrop of geopolitical tensions and fluctuating energy prices, global markets have experienced mixed performances, with small-cap indices like the S&P MidCap 400 and Russell 2000 showing resilience by closing higher after a series of losses. As investors navigate these volatile conditions, identifying small-cap stocks that demonstrate strong fundamentals and insider activity can offer potential opportunities for those looking to capitalize on market inefficiencies.

Fabege (OM:FABG) is back on income investors’ radar after the board proposed a 2025 dividend of SEK 2.20 per share, to be paid in four quarterly instalments, subject to AGM approval. See our latest analysis for Fabege. The proposed 2025 dividend comes as Fabege’s share price sits at SEK75.05 after a 2.25% 1 day share price return, with short term momentum soft and longer term total shareholder returns mixed. This suggests sentiment is still recalibrating around income and risk. If this...

Hufvudstaden (OM:HUFV A) used its 19 March 2026 AGM to confirm a dividend of SEK 2.90 per share and announce that board member Peter Egardt declined re-election, developments investors may reassess. See our latest analysis for Hufvudstaden. The share price has reacted positively around the AGM, with a 1-day share price return of 2.86% and a 7.29% total shareholder return over the past year. However, the 30-day share price return of 9.04% and 3-year total shareholder return of 8.93% suggest...

As European markets navigate the uncertainty surrounding the Middle East conflict and its impact on energy prices, small-cap stocks have drawn attention for their potential resilience and growth opportunities. In this environment, identifying undervalued small-cap companies with insider buying can be a strategic approach to finding promising investments amid broader market volatility.

As European markets navigate the uncertainty surrounding the Middle East conflict and its impact on economic growth, investors are keenly observing how these developments influence stock valuations. In this context, identifying undervalued stocks becomes crucial, as they may present opportunities for those looking to capitalize on potential market inefficiencies amid ongoing geopolitical and economic challenges.

Essity (OM:ESSITY B) drew investor attention at its Annual General Meeting on 26 March 2026, where shareholders approved a dividend of SEK 8.75 per share for the 2025 financial year. See our latest analysis for Essity. Essity's latest dividend decision comes after a period where the share price return over the past month declined 15.11%, and the one year total shareholder return of 11.45% decline suggests recent momentum has softened, despite a positive 5 year total shareholder return of...

In March 2026, Evolution AB’s Board of Directors proposed that no dividend be distributed for the 2025 financial year, marking a clear pause in cash returns to shareholders. This decision puts renewed focus on how Evolution intends to deploy its cash between growth investments, regulatory demands, and shareholder returns. We’ll now examine how the proposed suspension of the 2025 dividend could reshape Evolution’s investment narrative and capital allocation story. The best AI stocks today...

Husqvarna (OM:HUSQ B) has just rolled out a refreshed 2026 lineup of residential riding and zero turn mowers, a product push aimed at homeowners gearing up for Spring that could influence how investors view the stock. See our latest analysis for Husqvarna. Despite the fresh mower launch and the upcoming 2025 results announcement on 26 March 2026, Husqvarna’s recent share price momentum has been weak, with a 30 day share price return of 15.4% and a five year total shareholder return of...

If you are wondering whether Getinge's share price matches the underlying value of the business, the next sections will walk through what the numbers are currently saying about that gap. Over recent periods the stock has been mixed, with a 1.3% return over 7 days, a 9.1% decline over 30 days, a 15.2% decline year to date, and a 12.3% decline over the past year. These moves come as investors continue to reassess medical equipment makers like Getinge, with sentiment often shifting quickly when...